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Echocardiographic determination of left ventricular mass index (LVMI) is
shown to be valuable in the assessment of cardiovascular risk. Determination
of LV geometry, including concentric remodeling (CRM), provides additional
prognostic information. In isolated systolic hypertension (ISH), the few
echocardiographic studies available show an increased LVMI, but criteria and
patient populations differ. No comparison with DH has been made, nor has
LV geometry (with CRM) been evaluated. We compared both LVMI and LV
geometry of newly-diagnosed ISH-patients with normotensives and DH-
patients, all previously untreated and from the same population.
Methods and Results
The echocardiographic LVMI of 97 previously untreated ISH-patients (4x
systolic blood pressure > 160 mmHg / diastolic < 95 mmHg) was clearly
elevated compared to age and sex-matched normotensives: 98 g/m versus 712
g/m (p<0.001). The geometric pattern was abnormal in most ISH-patients,2
with a high prevalence of CRM: 43%. Both LVMI and geometry of ISH-
patients did not differ significantly from DH-patients (LVMI: 92 g/m , CRM:2
56%). Gender differences in LV geometry in ISH were only present using the
Framingham-criteria, not with the Koren-criteria.
Conclusions
This study shows a high prevalence of concentric remodeling in elderly
with previously untreated ISH. The increase of LVMI and abnormality in LV
geometry are comparable with DH-patients, which further defines the place
of ISH as a cardiovascular risk factor in the elderly. Whether there are gender
differences in cardiac adaptation in ISH, and whether the geometric
classification can be used to adjust treatment, remain to be investigated.
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INTRODUCTION
Isolated systolic hypertension (ISH) has for long been known as an
important cardiovascular risk factor , and the results of the Systolic1-4
Hypertension in the Elderly Program have shown that its treatment may lead
to a favorable outcome . The high prevalence of ISH in the elderly represents5
a major public health issue . Decisions in its management and treatment may6
be supported by knowledge about the presence of cardiovascular end-organ
damage in these patients. An accepted method to assess this damage in
hypertensive patients is measurement of the echocardiographic left
ventricular mass index (LVMI). In diastolic hypertension, the occurrence of
increased LVMI, with or without meeting the criteria for left ventricular
hypertrophy (LVH), is a strong and independent risk factor for cardiovascular
events in different populations, including the elderly .7-10
Koren et al. showed that also the geometry of the left ventricle bears
prognostic significance . The relationship of cardiovascular risk to the pattern11
of geometry: normal < concentric remodeling < eccentric LVH < concentric
LVH, was recently confirmed in hypertensive patients in a study from
Verdecchia et al. . In contrast to the original article by Koren they also12
included the interventricular septal thickness in calculation of LV geometry,
instead of only the posterior wall. This may alter the results since, as they
have described, isolated septal thickening might occur in hypertension .13
Another point of discussion is whether gender-dependent or gender-
independent criteria for LVH should be used; this obviously influences any
analysis of differences between males and females in LV adaptation in
hypertension .14
So far, very few studies have addressed LVMI in the elderly with ISH.
Comparison of the results of these studies is hampered by differences in
methodology and patient recruitment: the largest study (Cardiovascular
Health study) is unclear in the indexation of left ventricular mass, while
others are done in selected groups of patients, or use different criteria . No14-16
comparisons are presented with elderly patients with diastolic hypertension,
and none of these studies has determined LV geometry.
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The objective of this study was to determine the impact of previously
untreated ISH on left ventricular mass and geometry in elderly selected from
a population survey. The results are compared with an age- and sex-matched
normotensive control-group, and with patients with diastolic hypertension
from the same population survey.




A population screening program was done in a rural municipality
(Achtkarspelen) in The Netherlands. All inhabitants between 60 and 75 years
of age were invited to participate. After five minutes rest, the sitting blood
pressure (BP) was measured by trained volunteers using a
sphygmomanometer. If BP was elevated (for systolic BP: >160 mmHg) the BP
measurement was repeated by a physician. If BP remained elevated, the
patient was invited for a third and fourth measurement on two separate
occasions. Patients were defined to have isolated systolic hypertension (ISH)
if untreated systolic BP was >160 mmHg at each measurement, with diastolic
BP <95 mmHg on at least the last two occasions, and average diastolic BP less
than 95 mmHg. All patients fulfilling these criteria were eligible for
investigation of echocardiographic end-organ damage. Exclusion criteria for
this study were: recent myocardial infarction (<three months),
cerebrovascular accident (<one year), symptomatic congestive heart failure,
hemodynamically significant valvular heart disease or cardiac arrhythmia
(other than atrial fibrillation), or any other disabling medical condition
hampering patient participation. Patients were also excluded if both apical
and parasternal echocardiographic views were inadequate for obtaining
measurements. The general physician was consulted about patient eligibility
for further investigation. The study was approved by the Medical Ethical
Committee of the Groningen University Hospital, and written informed
consent was obtained.
A group of normotensive controls was selected from the same program (BP
at first measurement <160/95 mmHg, and unknown with hypertension).
They were matched to the ISH-patients for age, sex and a functional
classification (Duke activity status index) .17
Results of the ISH-patients were also compared with those of patients with
diastolic hypertension (DH). This group consisted of all DH-patients found in
the same population survey, with DH defined as untreated average diastolic
BP > 95 mm Hg (and <115 mmHg), measured on three separate occasions.
Exclusion criteria were the same as for ISH-patients, with addition of diabetes
mellitus (due to a planned intervention trial).
All patients (ISH and DH) and normotensive controls underwent a 24-hour
ambulatory blood pressure measurement (ABP) (SpaceLabs 90207; SpaceLabs
Inc. Washington, USA). Measurements were done every 30 minutes during
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the day (07.00-23.00 hours) and every 60 minutes during the night (23.00-07.00
hours); data were analyzed without data-editing using time-weighed means.
The history of smoking, diabetes, and myocardial infarction was obtained.
Height and weight were measured, and body mass index was calculated. The
fasting serum lipid profile, including high density lipoprotein-cholesterol and
triglycerides, was measured with conventional assay methods. Fasting serum
glucose was also determined; patients with plasma glucose >7.8 mmol/l
(WHO-criterium) were considered to be diabetic, in addition to those already
known with, or on treatment for diabetes mellitus.
Echocardiographic examination and LV mass calculations
The echocardiographic dimensions were measured with an Acuson (128 XP-
5, Acuson Corp., USA; transducer 2-2.5 MHz) according to the Penn-
convention, in the left decubitus position. Measurements of the left
ventricular internal end-diastolic (EDD) and end-systolic diameters, and of
interventricular septal (IVS) and posterior wall thicknesses (PWT) were
obtained from a standard parasternal long axis view. Measurements were
made from 2-D images perpendicular to the long axis of the left ventricle. The
left atrial dimension was measured in both the parasternal and the apical
view. All dimensions are averages of three end-expiratory measurements in
sinus rhythm (five in case of atrial fibrillation). Measurements were
performed on-line, by the same echocardiographer and videotaped. Intra-
observer variability of the echocardiographer (WFH), measured before start of
study, was within a 5% error margin. Left ventricular mass was calculated
according to the formula as corrected by Devereux and Reicheck :18,19
LVMI = 1.04 * ((IVS + PWT + EDD) - EDD ) - 13.6 ;3 3
and indexed for body surface area.
In the geometric analysis of Koren et al. LV geometry is subdivided using
presence or absence of LVH (defined as LVMI >125 g/m ) and of increased2
relative wall thickness (RWT= 2 x PWT/EDD; cutoff value: >0.45) . A normal11
RWT and no LVH is defined as normal geometry; LVH is subdivided into
concentric LVH when RWT is increased, and eccentric LVH when RWT is
normal. The pattern of increased RWT without LVH is called concentric
remodeling. In ISH, the geometric classification is also analyzed per gender to
investigate possible differences in cardiac adaptation.
For discussion purposes, two extra calculations were performed: first, the
geometric classification was repeated using the Framingham-criteria, with
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LVMI indexed for height and sex-different cutoff values for LVH: 143 g/m for
males, and 102 g/m for females . Also, the relative wall thickness was14
recalculated with the septal wall thickness, and with the sum of posterior and
septal wall in the calculation of LV geometry.
Statistical analysis
Data are presented as mean + standard deviation. Differences among the
three groups are analyzed with Pearson chi-square testing in the case of
nominal data (Fishers' exact test in case of low numbers), and with one-way
analysis of variance (ANOVA) in case of continuous variables, with posthoc
corrections for multiple comparisons (Tukey's honestly significant difference).
Differences between two groups, as in analysis of gender, are calculated using
Student's t-test. Odds ratios are calculated for ISH-patients with the
normotensive patients as case-controls, and are presented with 95%
confidence intervals. Differences are considered statistically significant when









gender (% males) 49 59 49
age (years) 68 + 4^ 63 + 3* 67 + 4
body mass index (kg/m )2 27.2 + 3.5^ 28.9 + 3.3* 26.1 + 3.4
total-HDL cholesterol  ratio 5.3 + 1.6* 5.5 + 1.5* 6.1 + 2.2
diabetes (%) 5 0‡ 4
smokers (%) 28* 42* 11
previous myocardial infarction (%) 2 0 5
Table 1. Baseline characteristics and risk factors of patients with isolated systolic
hypertension (ISH), diastolic hypertension (DH) and normotensive controls. 
Abbreviations: HDL= high density lipoprotein (-cholesterol). *= p<0.05 compared with
controls; ^: p<0.05 compared with DH. ‡: diabetes was excluded in DH.
RESULTS
Of the 2776 inhabitants aged 60-74 years 1812 (65.2%) attended the
screening. After four measurements 150 persons met the criteria for ISH
(prevalence 8.3%). Of these, 97 patients participated in further
echocardiographic examination. Reasons for ineligibility were mainly lack of
interest by the patients (n= 30) or if they were considered unsuitable for
investigation by the general practitioner consulted (n= 12); major exclusion
criteria were met by 11 patients. The results were compared with those of 50
patients with previously untreated diastolic hypertension (DH), and with 97
normotensive controls matched to ISH-patients for age and sex.
Baseline characteristics and blood pressure measurements
Table 1 presents the baseline characteristics of the three groups, including
the other cardiovascular risk factors. Age and gender of ISH-patients and
controls were equal due to matching. The DH-patients, although recruited
from the same age-category of 60-74 years, were slightly, but significantly,
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ISH DH controls
systolic BP   186 + 12.7* 182 + 16.4* 141 + 10.7
diastolic BP 87 + 5.9*^ 104 + 5.2* 79 + 6.7
24 h-avg. systolic ABP 138 + 13.6* 137 + 16.8* 120 + 10.5
24 h-avg. diastolic ABP 78 + 8.3*^ 85 + 8.9* 73 + 6.3
daytime ABP 143* / 82*^ 140* / 88* 124 / 77
nighttime ABP 126* / 68*^ 128* / 76* 111 / 65
heart rate (bpm) 76 + 12 80 + 12 79 + 13
Table 2. Results of office and ambulatory blood pressure measurements
Abbreviations: ISH and DH: see previously; (A)BP = (ambulatory) blood
pressure.   *= p<0.05 compared with controls (ISH and DH); ^: p<0.05
compared with DH (ISH).
younger compared with the ISH-patients (and controls). Gender distribution
of DH-patients did not differ from ISH-patients and controls. The body mass
index of patients with diastolic hypertension (DH) was significantly higher
compared with controls, but not with ISH-patients. There were no significant
differences among the three groups in body surface area or length, which is
used for indexation of left ventricular mass. Some significant differences
could be observed in the other cardiovascular risk factors between the two
hypertensive groups and the normotensive controls: both hypertensive
groups contained more smokers; and the ratio of total to high density
lipoprotein (HDL) cholesterol was higher in the control group (due to lower
HDL-C).
Table 2 shows the results of the office and ambulatory blood pressure
measurements (ABP). Most of the differences in office blood pressures can be
explained by the different entrance criteria of the three groups; these
differences were confirmed in patterns of 24-hour ambulatory measurements.
All values of ISH-patients were significantly higher compared with
normotensive controls, including diastolic blood pressure. Diastolic blood
pressure values of DH-patients were higher compared with ISH-patients and
controls. Systolic blood pressure of the ISH-patients did not differ from that of
DH-patients, with office as well as ambulatory measurements. The difference
between daytime and nighttime measurements (the "dipping" phenomenon)




LVMI (g/m )2 97.8 + 19.9* 92.0 + 20.4* 70.3 + 16.5
LVH (%) 9 9 2
RWT 0.46 + .07* 0.46 + .06* 0.39 + .05
IVS (mm) 10.0 + 1.1* 10.3 + 1.2* 8.6 + 1.0
PWT (mm) 10.3 + 1.1* 10.1 + 1.2* 8.4 + 0.9
EDD (mm) 44.9 + 4.1* 44.1 + 3.6* 43.5 + 4.5 
ESD (mm) 30.3 + 4.1 32.1 + 3.5 31.7 + 4.4 
LA-ps (mm) 35.7 + 4.2* 35.7 + 4.5 34.0 + 4.4
Table 3. Echocardiographic results
Abbreviations: LVMI = left ventricular mass index; LVH = LV hypertrophy; RWT =
relative wall thickness; IVS= interventricular septal thickness; PWT = posterior wall
thickness; EDD/ESD= end-diastolic/end-systolic dimension; LA-ps= left atrium
dimension - parasternal view.   
*= p<0,05 compared with controls; ^: p<0.05 compared with DH
Echocardiographic results
The results of the echocardiographic measurements are presented in Table
3. One ISH-patient and three controls had inadequate parasternal views for
LV mass measurement; therefore, the results are shown of 96 ISH-patients
and 94 controls, and of 50 DH-patients.
When comparing ISH-patients with normotensive controls, the left
ventricular mass index is significantly increased in the ISH-patients, due to
thickening of both the interventricular septal and posterior wall and to an
increase of the end-diastolic dimension. The relative difference in wall
thickness appears to be larger than the increase of the end-diastolic
dimension, as is shown by the significantly increased relative wall thickness
(RWT) of ISH-patients. The percentage of LVH (defined as LVMI > 125 g/m )2
in ISH-patients is only slightly, not significantly, higher compared with the
normotensive controls. The left atrial dimension is significantly increased in
ISH-patients compared with controls in the parasternal view only.
When comparing results of ISH with DH-patients, all the results of LV mass
measurements are comparable. LVMI, RWT and both wall and end-diastolic
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Figure 1. Result of LV geometric classification in isolated systolic (ISH) and diastolic
hypertension (DH), and normotensive controls (Koren-criteria). 
The result of the LV geometric classification according to Koren is depicted
in Figure 1. Overall, LV geometry of ISH-patients clearly differed from the
normotensive controls (p< 0.001). Most of the normotensive controls (86%)
had a normal geometry, versus 48% of ISH-patients. Total LVH-prevalence in
ISH-patients was 9% (controls: 2%), without an apparent difference between
concentric and eccentric LVH. Concentric remodeling was found in 43% of
ISH-patients versus 12% of controls; expressed in odds ratio ISH-patients
were 6.5 times more likely (95% CI: 3.0 - 13.8; p< 0.001) to have this pattern
compared with the controls. Almost half (47%) of ISH-patients who might
have been considered as normal because of absence of LVH, have this
abnormal pattern of increased wall thickness.
When comparing the LV geometric pattern of ISH with DH-patients, no
significant difference is found (Pearson chi-square: p= 0.423). The percentage
of LVH in both groups is 9%; concentric remodeling in DH is present in 56%.








































Figure 2. Results of LV geometry according to gender.
- top panel: with use of Koren-criteria (LVH > 125 g/m2): difference N.S.
- lower panel: with Framingham criteria (males > 143 g/m, and females > 102 g/m): P< 0.05
With the Koren-criteria, analysis by gender of LV geometry in ISH showed
no significant differences between males and females (figure 2: top panel).
Eccentric LVH appeared to be more frequent in males with ISH; when
patients with LVH were analyzed separately this difference was of borderline
significance (p= 0.058). When the gender-dependent criteria of the
Framingham Heart study were applied to this population, the results were
remarkably different and did reach overall statistical significance (p < 0.05;
lower panel figure 2). Female ISH-patients showed more often an abnormal
geometric pattern: overall percentage of LVH was 43% with the Framingham
criteria, versus 6% with the original Koren criteria. These different results
appeared to be due solely to a different classification of females; the results of
males were comparable to those of the Koren-classification.
Concerning asymmetry of LV hypertrophy, we did not often find isolated
septal wall thickening, neither in ISH-patients nor in DH-patients and in
normotensive controls. Only two ISH-patients had a ratio of > 1.3 of one wall
thickness to the opposite side ; however, in both cases this was increased13
thickness of the posterior wall instead of increased septal thickening. The
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influence of which LV wall thickness was used in the calculation of RWT, and
the resulting LV geometric classification, was only minor. The percentage of
increased RWT varied little when applying the original formula with the
posterior wall thickness (rate: 34%), with the septal thickness (rate: 32% of all




This study shows that the echocardiographic LV mass and geometric
pattern in patients with previously untreated isolated systolic hypertension
(ISH) are clearly abnormal, comparable with results of patients with diastolic
hypertension (DH) and significantly different from normotensive controls.
The pattern of abnormality is mainly an increase of wall thickness, apart from
enlargement of the ventricles. Results of the geometric classification show
that the majority of ISH-patients have an abnormal LV geometry, with a
moderate prevalence of LVH but a high prevalence of concentric remodeling.
This abnormal pattern of increased wall thickness is found in almost half of
the ISH-patients who were otherwise perhaps considered normal because of
the absence of LVH. We therefore conclude that these patients with ISH from
a general population clearly show an increased prevalence of cardiac end-
organ damage, to a level comparable with patients with DH. The importance
of this observation is that all patients in this population-based study are
previously untreated, which avoids any interference of medication on results.
With the proven attributable cardiovascular risk of increased LVMI and
abnormal LV geometry, this further defines the cardiovascular risk of ISH in a
general population.
Interestingly, the results in ISH and DH are comparable, despite the fact
that the underlying pathophysiological vascular changes are almost opposed
between ISH and DH: in ISH distensibility of larger arteries is increased with
no or little change in peripheral resistance, while in DH peripheral resistance
is clearly increased . In absence of (invasive) hemodynamic measurements20
no clear explanation can be given except that hemodynamic load, as derived
from values of LV mass and geometry, apparently is equal in these patient
groups.
Studies on echocardiography in ISH are rather scarce, often including only
small numbers of ISH-patients with varying selection criteria . The size of20,21
this study is second only to the Cardiovascular Health study, and (slightly)
larger than the SHEP-study and the Framingham ISH- report . All of these14-16
studies have shown a higher LVMI in ISH-patients compared with
normotensive controls. However, patient selection and criteria used differ,
which hampers comparison of results, and none of these studies included a
comparable group of diastolic hypertensives. In the Cardiovascular Health
Study, only the results of unindexed LV mass are reported, without separate
results on wall thickness and internal dimensions, which disables analysis of
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geometric changes . Comparison of the results with the ISH-patients from12
the Framingham Heart study is complicated by the different indexation of
LVMI used (for height instead of for body surface area) . Such a different14
indexation may lead to markedly different results, as is shown in our results
on gender differences in ISH. The results of LV mass measurements in a
subpopulation of the Systolic Hypertension in the Elderly Program (SHEP)-
study are to some extent comparable with the present study, although the
selection of patients differs . In the SHEPstudy only 1% of referred patients16
finally participated, including previously treated patients. In our study,
almost two-third (65%) of all detected ISH-patients were included, all of them
previously untreated.
In the present study, some possible sources of bias must be discussed. First,
although attendance rate was rather high (60%), this study might as any
screening study suffer from voluntary bias: healthy and health-conscious
persons are more likely to attend. To analyze the possibility of differences in
blood pressure and health status (number of chronic diseases registered by
questionnaire), a non-responder investigation was done. Those not
attending did suffer from slightly more chronic diseases compared with the
attendants, and a somewhat lower blood pressure, but differences were not
significant. Secondly, of the 150 ISH-patients found in the screening, 97
underwent echocardiographic examination. Although this is a much higher
percentage (65%) when compared with some other reports, this can also be a
possible source for bias. However, only a minor portion was excluded due to
concomitant diseases, among which several for non-cardiovascular reasons;
most patients refused further investigation. Finally, a remark could be made
that inclusion criteria for ISH-patients in this study was diastolic BP < 95
mmHg, as opposed to other (North American) criteria of < 90 mmHg. This
was of no influence to the present results: LVMI of those patients with
inclusion diastolic BP 90-94 mmHg was 94.7 g/m , and thus comparable with2
mean value of total group, and prevalence of concentric remodeling was 45%,
with no patients with LVH in this group.
Previous studies have suggested a possible difference in cardiac adaptation
in ISH with sex: more concentric hypertrophy in females, and more eccentric
ones in males . This pattern is also observed in elderly patients with LV14
pressure overload by aortic stenosis . In such analyses the influence of use of22
different criteria is very important. When using the original criteria of Koren,
we could not confirm such a difference, although there was a trend towards
more eccentric LVH in males. However, when applying the (gender-specific)
criteria of the Framingham Heart study to our patients, a markedly difference
in geometry in females is seen, resulting in a significant difference between
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geometry of ISH-males and females. This is probably due to the rather large
difference in criteria for LVH for males and females: 143 g/m versus 102 g/m;
especially prevalence of abnormal patterns in females increased considerably
with application of these criteria.
A further point of discussion is whether only the posterior wall should be
used in calculation of RWT and thus LV geometry (Koren), or the
interventricular septal thickness as well (Verdecchia) . Not only does it seem13
illogical to define a pattern as "concentric" if only one side of the LV wall is
included; more important, Verdecchia could not observe an significant
difference in cardiovascular risk for concentric remodeling when only the
posterior wall thickness was included . We found that results were13
comparable with inclusion of either one or both walls; we did not observe a
significant prevalence of isolated septal thickening. In our experience, a large
proportion of the elderly shows an angling of the left ventricle towards the
echocardiographic transducer, and this is known to be a possible source of
overestimation especially of the septal thickness with M-mode measurement
. It is for this reason that we use 2-D measurement of wall thickness and23,24
lumen diameters in our laboratory. This makes it possible to do measurements
perpendicular to the LV long axis and thus avoid a possible overestimation.
In conclusion, this study is one of the very first to show that
echocardiographic LV mass index and geometry in patients with ISH are
comparable with patients with diastolic hypertension. A large number of
those perhaps initially considered to be normal because of the absence of
LVH show concentric remodeling, which indicates an increased
cardiovascular risk for these patients. These results further define the place of
ISH as a cardiovascular risk factor; it indicates that the risk of ISH is no less
than that of diastolic hypertension in the elderly. It remains to be established
which criteria are most predictive, and whether results from geometric
classification may be used to adjust treatment.
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